It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
AgRP neurons drive hunger, and excessive nutrient intake is the primary driver of obesity and associated metabolic disorders. While many factors impacting central regulation of feeding behavior have been established, the role of microRNAs in this process is poorly understood. Utilizing unique mouse models, we demonstrate that miR-33 plays a critical role in the regulation of AgRP neurons, and that loss of miR-33 leads to increased feeding, obesity, and metabolic dysfunction in mice. These effects include the regulation of multiple miR-33 target genes involved in mitochondrial biogenesis and fatty acid metabolism. Our findings elucidate a key regulatory pathway regulated by a non-coding RNA that impacts hunger by controlling multiple bioenergetic processes associated with the activation of AgRP neurons, providing alternative therapeutic approaches to modulate feeding behavior and associated metabolic diseases.
AgRP neurons regulate feeding behavior by promoting signals of hunger. Here, the authors show that miR-33, represses the activity of AgRP neurons, and selective loss of miR-33 in AgRP neurons promotes obesity and metabolic dysfunction in mice.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Yale University School of Medicine, Vascular Biology and Therapeutics Program, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University School of Medicine, Department of Comparative Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710); Yale Center for Molecular and System Metabolism. Yale University School of Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710); Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Experimental Gerontology Section, Baltimore, USA (GRID:grid.419475.a) (ISNI:0000 0000 9372 4913)
2 Yale University School of Medicine, Vascular Biology and Therapeutics Program, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University School of Medicine, Department of Comparative Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710); Yale Center for Molecular and System Metabolism. Yale University School of Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710)
3 Yale University School of Medicine, Department of Comparative Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710); Yale Center for Molecular and System Metabolism. Yale University School of Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710); Laboratory of Glia -Neuron Interactions in the control of Hunger. Achucarro Basque Center for Neuroscience, Leioa, Spain (GRID:grid.427629.c); Basque Foundation for Science, IKERBASQUE, Bilbao, Spain (GRID:grid.424810.b) (ISNI:0000 0004 0467 2314)
4 Yale University School of Medicine, Department of Comparative Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710)
5 Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Experimental Gerontology Section, Baltimore, USA (GRID:grid.419475.a) (ISNI:0000 0000 9372 4913)
6 Yale University School of Medicine, Vascular Biology and Therapeutics Program, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University School of Medicine, Department of Comparative Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710); Yale Center for Molecular and System Metabolism. Yale University School of Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710); Department of Pathology. Yale University School of Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
7 Yale University School of Medicine, Department of Comparative Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710); Yale Center for Molecular and System Metabolism. Yale University School of Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710); Laboratory of Glia -Neuron Interactions in the control of Hunger. Achucarro Basque Center for Neuroscience, Leioa, Spain (GRID:grid.427629.c); Basque Foundation for Science, IKERBASQUE, Bilbao, Spain (GRID:grid.424810.b) (ISNI:0000 0004 0467 2314); Department of Neuroscience. Yale University School of Medicine, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)